Clinical trial
Novel Approaches to Target MECOM/EVI1 in Acute Myeloid Leukemia
NCT05839392 is registered in ClinicalTrials.gov with Gruppo Italiano Malattie EMatologiche dell'Adulto as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Novel Approaches to Target MECOM/EVI1 in Acute Myeloid Leukemia
- Lead sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- December 13, 2023
- Completion date
- December 31, 2026
- Enrollment
- 24 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aml, adult